Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of PD-1 Inhibition for the Prevention of Colon Adenomas in Patients With Lynch Syndrome and a History of Partial Colectomy

NCT03631641 is registered in ClinicalTrials.gov with John Hays as lead sponsor.

NCT NCT03631641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03631641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of PD-1 Inhibition for the Prevention of Colon Adenomas in Patients With Lynch Syndrome and a History of Partial Colectomy
Lead sponsor
John Hays
Phase
Phase 2
Overall status
Terminated
Start date
October 4, 2018
Completion date
January 25, 2021
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon adenoma, colon carcinoma, lynch syndrome, mlh1 gene mutation, msh2 gene mutation